Following Ang II infusion, ANGPTL8 sh-RNA significantly reduced the incidence of AAA (30% vs. 80%, P<0.05) and maximal diameter of the abdominal aorta (P<0.05) compared with ApoE−/− controls (Figure 6C,D). This evidence concerns the gene APOE and triple-A syndrome.